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In the recent literature devoted to the results of the study, formulation and application of polyhydroxyalkanoa-
tes (PHA), contains a wealth of experimental and clinical data on efficacy and safety of using these polymers with
biomedical goals. However, the application of PHA, both independently and in combination with other drugs and
substances that must surely have its advantages and disadvantages. It should be noted the complete absence, in-
formation on contraindications and complications of the PHA, and insufficient data on the patterns of degradation
of PHA in vivo, and morphological processes connected with it of scientific literature.
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Introduction. Successful introduction of themethods of
long-term cultivation of cells, including the progenitor
cells of specialized tissues, into the practice of experi-
mental biology and medicine became the prerequisite
of the elaboration of novel technologies and approaches
of the reconstructive medicine [1]. Some recent works
have reported the application ofmesenchymal stem cells
(MSC) for the purposes of regenerative medicine and
tissue engineering, which enables the reconstruction of
three-dimensional structure of the lost or damaged tis-
sues and even whole organs [3–5] rather than just resto-
ration of some tissue, for instance, after skin injuries
[2]. The interdisciplinary research in tissue engineering
is directed, first of all, at the elaboration of novel bio-
composite materials with improved properties [6–9].
Themain principle is the creation of biodegradable car-
riers and their application in combination with the donor
MSC and/or bioactive substances for implantation into
the damaged organ or tissue [10].
Therefore, in the last decade an enhanced attention
of scientists and technologists has been paid to the new
class of polymers – polyhydroxyalkanoates (PHA).
PHA characteristics and production PHA are alipha-
tic polyesters, the polymers of hydroxy derivatives of na-
tural fatty acids –-hydroxybutyric and-hydroxyvale-
ric. There are over 150 different monomers in this fa-
mily which can give rise to the materials with various
properties [11].
The melting temperature of PHA is up to 180 oC,
the decomposition point is over 200 oC, and the molecu-
lar mass is 100–800 kDa. The most important represen-
tatives of this family are polyhydroxybutyrate (PHB)
and polyhydroxyvalerate (PHV).
The industrial types of PHA are copolymers of PHB
and PHV. All the PHA homologues are the products of
bacterial activity [12], and for practical purposes they
are manufactured by the biotechnological method of
bacterial fermentation from vegetative sugars, for in-
stance, glucose.
In the past, PHA were too expensive for widespread
implementation. The current efforts are aimed at decre-
asing the cost of polymers by producing them from fer-
mentable sugars, obtained from relatively inexpensive
sources, for instance, from the sugar industry waste,
from renewable plant rawmaterials [13]. At present PHA,
PHB in particular, are produced on the industrial scale
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PHA properties and spheres of application. Re-
cently in China, Southern Korea, Japan, India, Brazil
and Russia sharply increased the number of scientific
publications devoted to extremely interesting and use-
ful properties of PHA. The most active and successful
Russian scientists from the Siberian federal university
(Krasnoyarsk) elaborated the technology of PHA pro-
duction, and in 2005 designed and launched the first do-
mestic pilot manufacture of biocompatible polymers of
different structure, resorbable in biological media, as well
as fabrication of experimental goods for biomedical pur-
poses. The developed PHA retention sutures, tubular
endoprostheses and membranes are approved for clini-
cal trials.
To date there has been accumulated a considerable
experimental database, demonstrating valuable PHA
properties, such as thermoplasticity, biocompatibility
and, above all, biological degradability [12, 14, 15].
PHA are known for their non-susceptibility to hyd-
rolytic degradation in aqueous media, therefore they
are characterized by slow (months and years) kinetics
of bioresorption, and their destruction in biological me-
dia is not accompanied with the change in the active
reaction of the medium [14], which allows their appli-
cation as a carrier-substrate for functioning cells [16].
PHA may be used as matrices for deposition, delivery
and long-term controlled release of preparations (drugs,
pesticides) [17–19], in particular, rubomycinum [20].
This class of polymers is widely used as amatrix or scaf-
fold for the MSC delivery to tissues [21–24].
The interrelationship of PHA and the cellular en-
vironment in vitro. Shishatskaya et al. [10] applied
PHA in different phase states (solutions, emulsions,
powders) to obtain and to study the structure and pro-
perties of two- and three-dimensional matrices in the
form of flexible transparent films, membranes, super-
fine fibers, microparticles, sponges, voluminous solid
and porous constructions. Glass and polystyrene were
used as controls. The suitability of PHA-matrices for
the cultivation of cells in vitrowas confirmed. The bio-
compatibility and cytotoxicity of matrices from PHA
were estimated on the animal cells of different origin –
mesenchymal (fibroblasts and cells of endothelium) and
endodermal (hepatocytes) ones as well as on the pri-
mary culture of osteoblasts, isolated from the cells of
red bone marrow. The investigation was performed
using the microscopy and intravital staining of cells
with trypan blue. The synthesis of proteins and DNA by
the cultivated cells as well as the cellular and medicinal
cytotoxicity were investigated using the 3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay, which is based on the ability of the mito-
chondrial dehydrogenases to convert the soluble MTT
into formazan, crystallized inside the cell. It was de-
monstrated that the morphology of cells, cultivated at
direct contact with the matrices surface, did not differ
from that of the control cells, cultivated on glass or po-
lystyrene. The direct contact of the cells with the sur-
face of PHAmatrices neither reduced the cell viability,
nor led to the inhibition of the DNA synthesis and the
proliferative activity.
Therefore, the absence of cytotoxicity of the PHA
matrices was proved as well as their high biocompati-
bility regarding the investigated cultivated cells. Besi-
des, the osteogenetic potential of PHA-constructs was
demonstrated in vitro [21]. These works did not reveal
any differences between the biological activity of PHB
and copolymer samples of PHB/PHV.
Previously Deng et al. [25] used the cultivation of
chondrocytes to demonstrate that, compared to pure
PHB, the mixtures of polymers (polyhydroxybutyrate-
Co-hydroxyhexanoate/polyhydroxybutyrate) are the
most suitable for the cell cultivation. Zhao et al. [26]
showed a better biocompatibility of the PHA mixture
(polyhydroxybutyrate-Co-hydroxyhexanoate/polyhyd-
roxybutyrate) in comparison with the pure polyhydro-
xybutyrate-Co-hydroxyhexanoate.
The recent studies have shown that PHA may pro-
mote the growth and differentiation of stem cells, in
particular, into neurons after CNS injury [27], and that
PHA stimulate the growth of fibroblasts in vitro [28].
However, such publications are not numerous and the
last ones are dated 2011, but the probability of the im-
pact and change in the cell differentiation during the in-
teraction with PHA cannot be rejected and is to be consi-
dered while using these polymers as scaffolds.
Some differences are revealed between the surface
properties of the films, made of PHA of various kinds,
in particular, of poly-3-hydroxybutyrate and poly-3-
hydroxybutyrate-Co-3-hydroxyvalerate, which, in turn,
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may impact the level of cell adhesion on the surface of
these films. Additionally, the conclusion was made that
the biomaterials for tissue engineering are specific for
certain type of cells. For instance, poly-3-hydroxybu-
tyrate is more suitable for the cultivation of olfactory
ensheathing (Schultze) cells whereas poly-3-hydroxy-
butyrate-Co-3-hydroxyvalerate – for MSC [22].
The interrelationship of PHA and the macroor-
ganism in vivo. The acute and long-term experiments
on laboratory animals demonstrated that the PHA de-
gradation depends on the chemical structure of the poly-
mer, on the place of implantation and the form of the
product; it occurs slowly via humoral and cellular path-
ways, mainly, from the surface of the product without
the formation of local defects and sharp decline in soli-
dity. The PHA degradation involves the macrophages
and gigantic cells of foreign bodies with the high activi-
ty of acid phosphatase, correlating with the activity of
the enzyme in the blood serum of animals. The main tar-
gets of polymer particles are the tissues of liver, kidneys
and spleen. The most active destruction of microparti-
cles of the polymer matrix occurs in spleen and liver.
PHAmay be used for the period of several months up to
a year; they neither cause inflammatory, necrotic, scle-
rotic and any other negative reactions in the surroun-
ding tissues nor prevent the reparation in vivo, which is
especially valuable for surgical sutures, endoprosthe-
ses and osteoimplants. The degradation of the polymer
structure becomes evident if the experiment lasts for 12
and more weeks [29, 30]. The experiments on the repa-
rative osteogenesis demonstrated that the implants ma-
de of PHB have pronounced directional osteoplastic
properties [21].
The works of Fedorov et al. [31] dedicated to the in-
vestigation and production of the PHB-based fibrous
and filmmaterials proved the reasonability of the use of
this polymer to apply the sheath on surgical sutures. The
obtained surgical material meets all the requirements of
the modern surgery. The mentioned requirements are
quite numerous, namely torpidity, mechanical perfor-
mance, atraumatic nature, i. e. the suture should not in-
terrupt the blood supply and cause the development of
necrosis, inflammation in the sutured tissues (the lat-
ter is achieved via sterilization, a lower capillarity and
prolonged bactericide properties). The suture material
should be nonhygroscopic, its biodegradation should
not occur prior to the terms, specified by the process of
wound healing.
It should be noted that in the literature along with
the results, testifying to high efficiency of the PHA ap-
plication for biomedical purposes, there are opposite da-
ta, indicating poor biodegradation or even the complete
absence of lysis of this class of polymers in the living or-
ganism [32–34].
The morphological and radiovisiographic methods
were used to study the regeneration of the damaged part
of the lower jaw bone of rats after the PHA application
(copolymer of 85 % of PHB and 15 % of PHV). The
opening in the bone, where PHA was applied, did not
change for five weeks of observation. No signs of the
PHA consolidation with the edge of the bone defect we-
re found. The polymer was surrounded by the fibrous
tissue with numerous cellular elements. There were no
signs of degradation of the artificial material at any mo-
ment during the experiment [32].
The controversial data were obtained while study-
ing the processes of regeneration of the damaged knee
joint cartilage of rats after the PHB/PHV implantation.
After the PHA application the destructive changes in
the damaged joints were much more pronounced than
in case of natural healing. No PHAwere found between
the joint surfaces during the observation. However,
sometimes PHA were revealed in lateral folds of the
joint capsule. More often small PHA fragments were
located in the soft tissues around the joint; they were en-
capsulated by the actively proliferating fibrous tissue
and deformed. There were neither macrophage and leu-
kocyte reactions to the foreign body nor the signs of de-
veloping granulomatous inflammatory process. At the
same time, there was no evidence of the PHA degrada-
tion [34].
The morphological methods were used to study the
reaction of the organism of rats after the implantation
of materials made of PHB/PHV. It was revealed that
the polymer implantation into the abdominal cavity is
followed by the active adhesive process, which results
in the formation of fibrotic folds between PHA and the
intestinal loops. The implanted PHA films under the skin
and in the muscle tissue are encapsulated by the thick
fibrous capsule. At the implantation of PHA superfine
fibers, the granulomas of the foreign body with peri-
focal inflammation and sclerosis of the adjacent tissues
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are formed in all the tissues. In these granulomas the
fragmentation of the polymer and phagocytosis by mac-
rophages occur with the formation of gigantic cells of
foreign bodies. The conclusion was made that after the
implantation into the organism, the PHAmaterials cau-
se active and pronounced chronic granulomatous in-
flammatory reaction and are destroyed very slowly by
macrophages [33].
This contradiction is likely to occur because of dif-
ferent interpretation of the data obtained. For instance,
Shishatskaya et al. [29, 30], based on the active mac-
rophage reaction in the place of PHA implantation,
made a conclusion about the PHA degradation. They
stated that it is rather a long-term process, the start of
which may be revealed only after 12 weeks.
Maiborodin et al. [33, 34], based on the same long-
term infiltration of peri-implant tissues by macropha-
ges, stated about the absence of the degradation of the-
se polymers. Due to the fact that these authors found the
PHA fragments in the tissues of rats one year after the
implantation, their conclusions seem more grounded.
The perspective of further studies on PHA. Re-
cently special attention is paid to the elaboration of new
ways of production and modification of PHA, aimed at
the improvement of their properties [6, 7, 9, 23, 35–38].
In particular, Ruth et al. [36] and Mauclairea et al. [8]
studied new types of PHA, poly-3-hydroxyoctanoate
(PHO) and poly-3-hydroxyundecanoate (PHUA), with
antibacterial properties.
There are some reports about the possibility of crea-
ting biodegradable carriers for MSC made not just of
PHB and PHV [21–24], but also of the composites of
these polymers with calcium phosphate [39, 40]; on the
basis of polyhydroxybutyrate-Co-hydroxyvalerate
(PHBV) with wollastonite (W). It was revealed that the
introduction of wollastonite into the construct impro-
ves the adhesion, the proliferation of the progenitor
cells and their differentiation into osteoblasts even in
the non-osteogenetic medium [41].
There are the works, confirming the best suitability
of 3D constructs of the mixture of 3-hydroxybutyrate,
3-hydroxyvalerate and 3-hydroxyhexanoate (terpolyes-
ter) for the cultivation of the nervous cells, if compared
to the copolymer (3-hydroxybutyrate/3-hydroxyhexa-
noate) and to the polymer of the other class – polylactic
acid (PLA) [27, 42].
Conclusions. At the modern stage of the develop-
ment of regenerative medicine there is the urgent ne-
cessity of implementation of new biocompatible func-
tional materials, which allow construction of the sys-
tems, capable of reproducing biological functions of the
living organism. It could be, in turn, a prerequisite of
creating bioartificial organs and tissues.
The literature contains numerous data on the reaso-
nability of using PHA in the reconstructive medicine,
cell and tissue engineering. However, noteworthy is the
deficiency of information on the contradictions and
complications, whereas only based on the thorough ana-
lysis of complete scope of available knowledge, the re-
liable conclusion can be made about the spheres of PHA
application. Additionally, there are still unsolved issues
on the kinetics and controllability of the PHA biodegra-
dation, the mechanisms of interaction of PHA products
with different cells and tissues in vivo.
Âçàºìîä³ÿ ïîë³ìåð³â ãðóïè ïîë³ã³äðîêñèàëêàíîàò³â ç êë³òèíàìè
³ òêàíèíàìè
². Â. Ìàéáîðîä³í, ². Â. Êóçíåöîâà, À. ². Øåâåëà, À. Î. Ìàíàºâ,
Ã. À. ×àñòèê³í
Ðåçþìå
Ó ë³òåðàòóð³ îñòàíí³õ ðîê³â, ïðèñâÿ÷åí³é ðåçóëüòàòàì âèâ÷åííÿ,
îòðèìàííÿ ³ çàñòîñóâàííÿ ïîë³ã³äðîêñèàëêàíîàò³â (ÏÃÀ), ì³ñòè-
òüñÿ áåçë³÷ åêñïåðèìåíòàëüíèõ ³ êë³í³÷íèõ äàíèõ ùîäî åôåêòèâ-
íîñò³ ³ áåçïåêè âèêîðèñòàííÿ öèõ ïîë³ìåð³â äëÿ ìåäèêî-á³îëîã³÷-
íèõ ïîòðåá. Ïðîòå çàñòîñóâàííÿ ÏÃÀ ÿê ñàìîñò³éíî, òàê ³ â êîì-
á³íàö³¿ ç ³íøèìè ïðåïàðàòàìè ³ ðå÷îâèíàìè, ïîçà ñóìí³âîì, ïî-
âèííî ìàòè ñâî¿ ïåðåâàãè ³ ñâî¿ íåäîë³êè. Âàðòî â³äì³òèòè ïîâíó
â³äñóòí³ñòü ó íàóêîâ³é ë³òåðàòóð³ â³äîìîñòåé ïðî ïðîòèïîêà-
çàííÿ ³ óñêëàäíåííÿ çà âèêîðèñòàííÿ ÏÃÀ, à òàêîæ íåäîñòàòíþ
ê³ëüê³ñòü äàíèõ ñòîñîâíî çàêîíîì³ðíîñòåé äåãðàäàö³¿ ÏÃÀ ó æè-
âîìó îðãàí³çì³ ³ ìîðôîëîã³÷íèõ ïðîöåñàõ, ç öèì ïîâ’ÿçàíèõ.
Êëþ÷îâ³ ñëîâà: ïîë³ã³äðîêñèàëêàíîàòè, ðåêîíñòðóêòèâíà ìå-
äèöèíà, á³îäåãðàäàö³ÿ, êë³òèíí³ òåõíîëîã³¿.
Âçàèìîäåéñòâèå ïîëèìåðîâ ãðóïïû ïîëèãèäðîêñèàëêàíîàòîâ
ñ êëåòêàìè è òêàíÿìè
È. Â. Ìàéáîðîäèí, È. Â. Êóçíåöîâà, À. È. Øåâåëà, À. À. Ìàíàåâ,
Ã. À. ×àñòèêèí
Ðåçþìå
Â ëèòåðàòóðå ïîñëåäíèõ ëåò, ïîñâÿùåííîé ðåçóëüòàòàì èçó÷å-
íèÿ, ïîëó÷åíèÿ è ïðèìåíåíèÿ ïîëèãèäðîêñèàëêàíîàòîâ (ÏÃÀ), ñî-
äåðæèòñÿ ìíîæåñòâî ýêñïåðèìåíòàëüíûõ è êëèíè÷åñêèõ äàí-
íûõ îá ýôôåêòèâíîñòè è áåçîïàñíîñòè èñïîëüçîâàíèÿ ýòèõ ïîëè-
ìåðîâ â ìåäèêî-áèîëîãè÷åñêèõ öåëÿõ. Îäíàêî ïðèìåíåíèå ÏÃÀ êàê
ñàìîñòîÿòåëüíî, òàê è â êîìáèíàöèè ñ äðóãèìè ïðåïàðàòàìè è
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âåùåñòâàìè, íåñîìíåííî, äîëæíî èìåòü ñâîè ïðåèìóùåñòâà è
ñâîè íåäîñòàòêè. Ñëåäóåò îòìåòèòü ïîëíîå îòñóòñòâèå â íà-
ó÷íîé ëèòåðàòóðå ñâåäåíèé î ïðîòèâîïîêàçàíèÿõ è îñëîæíåíèÿõ
ïðè èñïîëüçîâàíèè ÏÃÀ, à òàêæå íåäîñòàòî÷íîå êîëè÷åñòâî äàí-
íûõ î çàêîíîìåðíîñòÿõ äåãðàäàöèè ÏÃÀ âæèâîì îðãàíèçìå è ìîð-
ôîëîãè÷åñêèõ ïðîöåññàõ, ñ ýòèì ñâÿçàííûõ.
Êëþ÷åâûå ñëîâà: ïîëèãèäðîêñèàëêàíîàòû, ðåêîíñòðóêòèâíàÿ
ìåäèöèíà, áèîäåãðàäàöèÿ, êëåòî÷íûå òåõíîëîãèè.
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